Characteristics and long-term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic BRIT J HAEMATOL
Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection Haematologica
Human immunodeficiency virus-associated Lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Hemasphere
Front-line and second-line treatment for mantle cell lymphoma in clinical practice: A multicenter retrospective analysis Eur J Haematol
The interferon γ pathway enhances pluripotency and X-chromosome reactivation in iPSC reprogramming Sci Adv
Safety and efficacy of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated B-cell lymphoma: analysis of a phase 1 dose-finding study (CITADEL-112) LEUKEMIA LYMPHOMA
Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles Eur J Pharm Biopharm